Parental experiences of receiving genomic newborn screening results: findings from the BabyScreen+ study
Open Access
- 24 February 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- p. 1-8
Abstract
Genomic newborn screening (gNBS) provides the potential to offer significant health benefits. However, more evidence, including psychosocial impacts on parents, is needed before gNBS is ready for population-level implementation. The aim of this qualitative study was to explore parental experiences of receiving gNBS results from a prospective study, BabyScreen+. BabyScreen+ screened 1000 newborns for >600 genetic conditions that were early-onset, severe, and had management options available (prevention, surveillance or treatment). We interviewed parents three months after receiving their result. Interviews were analysed using reflexive thematic analysis, guided by Interpretive Description. Twenty-seven parents were interviewed, including nine who received a ‘high chance’ result for their newborn. Waiting for gNBS results was not unduly anxiety provoking. Low chance results provided psychosocial benefits including peace-of-mind and empowerment. Receiving a high chance result was unexpected and shocking, especially if the result was for a condition with significant treatment recommendations (e.g., transplantation). Psychosocial adaption to the subsequent diagnosis was an evolving process; access to genetic counselling, high-quality information and prompt referrals to specialists increased confidence in managing the condition and facilitated adaptation. All parents valued the high chance gNBS result given its clinical utility. The study provides support for gNBS by highlighting that it can provide valuable health information with minimal harms. Findings can be used to inform the implementation of population-scale gNBS.Keywords
This publication has 44 references indexed in Scilit:
- Expanded Newborn Screening Using Genome Sequencing for Early Actionable ConditionsJAMA, 2025
- Parental and child's psychosocial and financial burden living with an inherited metabolic disease identified by newborn screeningJournal of Inherited Metabolic Disease, 2024
- Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screeningJournal of Genetic Counseling, 2022
- Doing Reflexive Thematic Analysis2022
- Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq ProjectJAMA Pediatrics, 2021
- Principles of Genomic Newborn Screening ProgramsJAMA Network Open, 2021
- Genomic Sequencing for Newborn Screening: Results of the NC NEXUS ProjectThe American Journal of Human Genetics, 2020
- Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq ProjectThe American Journal of Human Genetics, 2019
- Newborn screening for Pompe disease: impact on familiesJournal of Inherited Metabolic Disease, 2018
- The Ethical Hazards and Programmatic Challenges of Genomic Newborn ScreeningJAMA, 2012